HEALTHCARE ROYALTY PARTNERS
We are a $3.0+ billion global healthcare investment firm. We invest primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the worldโs largest pharmaceutical companies. Over the past decade, our senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. For more information, visit www.healthcareroyalty.com.
HEALTHCARE ROYALTY PARTNERS
Social Links:
Industry:
Asset Management Biotechnology Financial Services Medical Device Pharmaceutical
Founded:
2007-01-01
Status:
Active
Contact:
203.487.8300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving Wordpress Plugins
Current Advisors List
Louis Berneman Lead Advisor @ HealthCare Royalty Partners Advisor 2009-01-01
Frank Armstrong SAB Member @ HealthCare Royalty Partners Board_member 2009-01-01
Current Employees Featured
Clarke B. Futch
Clarke B. Futch Chairman & Chief Executive Officer @ HealthCare Royalty Partners Chairman & Chief Executive Officer
Conrad Wang
Conrad Wang Principal @ HealthCare Royalty Partners Principal 2015-10-01
Paul J Hadden
Paul J Hadden Senior Managing Director @ HealthCare Royalty Partners Senior Managing Director
Timothy Bryant
Timothy Bryant General Counsel @ HealthCare Royalty Partners General Counsel
Gregory B. Brown, MD
Gregory B. Brown, MD Founding Managing Director @ HealthCare Royalty Partners Founding Managing Director 2007-01-01
Todd C. Davis
Todd C. Davis Founding Managing Director @ HealthCare Royalty Partners Founding Managing Director
Christopher White
Christopher White Chief Operating Officer @ HealthCare Royalty Partners Chief Operating Officer 2014-12-01
Thomas K. Conner
Thomas K. Conner CFO @ HealthCare Royalty Partners CFO 2011-01-01
Founder
Clarke B. Futch
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-08 | Clearside Biomedical | HealthCare Royalty Partners investment in Post-IPO Debt - Clearside Biomedical | 65 M USD |
2022-06-30 | Ardelyx | HealthCare Royalty Partners investment in Post-IPO Debt - Ardelyx | 20 M USD |
2022-06-16 | Rhythm Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals | 37.5 M USD |
2021-09-30 | Spero Therapeutics | HealthCare Royalty Partners investment in Post-IPO Debt - Spero Therapeutics | 125 M USD |
2019-03-04 | Portola Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Portola Pharmaceuticals | 125 M USD |
2019-01-08 | Coherus Biosciences | HealthCare Royalty Partners investment in Post-IPO Debt - Coherus Biosciences | 75 M USD |
2016-04-14 | TearScience | HealthCare Royalty Partners investment in Series D - TearScience | 19.23 M USD |
2015-02-13 | Invuity | HealthCare Royalty Partners investment in Private Equity Round - Invuity | 22.9 M USD |
2014-11-13 | Helomics | HealthCare Royalty Partners investment in Series E - Helomics | 60 M USD |
2014-09-18 | Cardiorentis | HealthCare Royalty Partners investment in Series A - Cardiorentis | 45 M EUR |